Search results
FDA expands RSV vaccine use to adults aged 50 to 59
Center for Infectious Disease Research and Policy· 6 days agoGSK said recent studies have shown RSV causes approximately 42,000 annual hospitalizations in adults aged 50 to 59.
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoThe vaccine, dubbed mResvia, was developed to protect people age 60 and older from RSV. Usually, RSV...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 7 days agoRecently, the company won a slightly delayed approval for its second-ever product, a vaccine to...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 7 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...
Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion
Zacks via Yahoo Finance· 7 days agoRoche's (RHHBY) Alecensa gets the European Commission's approval as the first and only targeted...
FDA: Shellfish from Oregon, Washington may have paralytic toxin
UPI· 6 days agoIn an advisory, the FDA told consumers to avoid oysters and bay clams harvested from Netarts and...
Study: High-dose general anesthesia doesn't raise risk of delirium after surgery
UPI· 7 days agoA study of more than 1,000 patients who had heart surgery at four hospitals in Canada found that the amount of anesthesia used did not affect the risk of delirium after surgery. Older adults ...
UPMC doctor: Important screenings to remember this Men’s Health Month
The Williamsport Sun-Gazette· 2 days agoBeyond just fathers, all men should take this opportunity to reflect on their health and wellness. An easy first step is to help get them started with an idea of what screenings to keep in mind ...